California insurers oppose enrollment period changes; California launches price transparency initiative;

News From Around the Web

> Despite regulators' moves to limit Procrit's use in cancer patients, Medicare paid U.S. oncologists $128 million in 2012 to administer the anemia drug, The Wall Street Journal reported. Article

> House Democrats want a hearing on the $1000-a-pill hepatitis C drug to better understand how Sovaldi's cost will affect the Medicare Part D program, according to The Hill. Article

> Insurers in California worry changes to open enrollment period rules will skew the risk pool and make premiums more volatile, LifeHealthPro reported. Article

Healthcare Finance News

> The California Department of Insurance tapped the University of California and the San Francisco-based Consumers Union to create a healthcare price transparency and quality database that will likely be ready to launch within a year. Article

> The consumer advocacy group Public Citizen urges hospitals and healthcare systems around the country to stop hosting special events that promote unnecessary testing, USA Today reported. Article

And Finally... Food that looks better tastes better. Article